nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—CYP2C19—Loratadine—atopic dermatitis	0.0761	0.151	CbGbCtD
Tapentadol—CYP2C19—Diphenhydramine—atopic dermatitis	0.0761	0.151	CbGbCtD
Tapentadol—CYP2C9—Loratadine—atopic dermatitis	0.0633	0.125	CbGbCtD
Tapentadol—CYP2C9—Diphenhydramine—atopic dermatitis	0.0633	0.125	CbGbCtD
Tapentadol—CYP2D6—Loratadine—atopic dermatitis	0.0579	0.115	CbGbCtD
Tapentadol—CYP2D6—Diphenhydramine—atopic dermatitis	0.0579	0.115	CbGbCtD
Tapentadol—CYP2C19—Prednisone—atopic dermatitis	0.0422	0.0835	CbGbCtD
Tapentadol—CYP2C19—Dexamethasone—atopic dermatitis	0.0263	0.0521	CbGbCtD
Tapentadol—CYP2C9—Dexamethasone—atopic dermatitis	0.0219	0.0433	CbGbCtD
Tapentadol—CYP2D6—Dexamethasone—atopic dermatitis	0.02	0.0396	CbGbCtD
Tapentadol—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000397	0.000977	CcSEcCtD
Tapentadol—Weight decreased—Prednisone—atopic dermatitis	0.000394	0.00097	CcSEcCtD
Tapentadol—Vision blurred—Prednisolone—atopic dermatitis	0.000394	0.000969	CcSEcCtD
Tapentadol—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000393	0.000968	CcSEcCtD
Tapentadol—Depression—Prednisone—atopic dermatitis	0.000387	0.000954	CcSEcCtD
Tapentadol—Visual impairment—Dexamethasone—atopic dermatitis	0.000386	0.00095	CcSEcCtD
Tapentadol—Visual impairment—Betamethasone—atopic dermatitis	0.000386	0.00095	CcSEcCtD
Tapentadol—Mental disorder—Methylprednisolone—atopic dermatitis	0.000386	0.00095	CcSEcCtD
Tapentadol—Malnutrition—Methylprednisolone—atopic dermatitis	0.000383	0.000944	CcSEcCtD
Tapentadol—Asthenia—Tacrolimus—atopic dermatitis	0.000383	0.000943	CcSEcCtD
Tapentadol—Angioedema—Prednisolone—atopic dermatitis	0.000382	0.00094	CcSEcCtD
Tapentadol—Pruritus—Tacrolimus—atopic dermatitis	0.000377	0.00093	CcSEcCtD
Tapentadol—Vertigo—Prednisolone—atopic dermatitis	0.000375	0.000924	CcSEcCtD
Tapentadol—Syncope—Prednisolone—atopic dermatitis	0.000374	0.000922	CcSEcCtD
Tapentadol—Eye disorder—Dexamethasone—atopic dermatitis	0.000374	0.000921	CcSEcCtD
Tapentadol—Eye disorder—Betamethasone—atopic dermatitis	0.000374	0.000921	CcSEcCtD
Tapentadol—Angioedema—Hydrocortisone—atopic dermatitis	0.000373	0.000918	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisolone—atopic dermatitis	0.000367	0.000904	CcSEcCtD
Tapentadol—Vertigo—Hydrocortisone—atopic dermatitis	0.000366	0.000902	CcSEcCtD
Tapentadol—Syncope—Hydrocortisone—atopic dermatitis	0.000366	0.000901	CcSEcCtD
Tapentadol—Diarrhoea—Tacrolimus—atopic dermatitis	0.000365	0.000899	CcSEcCtD
Tapentadol—Angiopathy—Betamethasone—atopic dermatitis	0.000363	0.000894	CcSEcCtD
Tapentadol—Angiopathy—Dexamethasone—atopic dermatitis	0.000363	0.000894	CcSEcCtD
Tapentadol—Convulsion—Prednisolone—atopic dermatitis	0.000362	0.000891	CcSEcCtD
Tapentadol—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000358	0.000883	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—atopic dermatitis	0.000355	0.000874	CcSEcCtD
Tapentadol—Convulsion—Hydrocortisone—atopic dermatitis	0.000353	0.00087	CcSEcCtD
Tapentadol—Dizziness—Tacrolimus—atopic dermatitis	0.000353	0.000869	CcSEcCtD
Tapentadol—Angioedema—Triamcinolone—atopic dermatitis	0.000351	0.000864	CcSEcCtD
Tapentadol—Angioedema—Methylprednisolone—atopic dermatitis	0.00035	0.000862	CcSEcCtD
Tapentadol—Hallucination—Prednisone—atopic dermatitis	0.000347	0.000854	CcSEcCtD
Tapentadol—Anxiety—Hydrocortisone—atopic dermatitis	0.000346	0.000852	CcSEcCtD
Tapentadol—Vertigo—Triamcinolone—atopic dermatitis	0.000345	0.00085	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000345	0.000849	CcSEcCtD
Tapentadol—Syncope—Triamcinolone—atopic dermatitis	0.000344	0.000848	CcSEcCtD
Tapentadol—Vertigo—Methylprednisolone—atopic dermatitis	0.000344	0.000848	CcSEcCtD
Tapentadol—Syncope—Methylprednisolone—atopic dermatitis	0.000344	0.000846	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—atopic dermatitis	0.000343	0.000844	CcSEcCtD
Tapentadol—Oedema—Prednisolone—atopic dermatitis	0.000341	0.000839	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000341	0.000839	CcSEcCtD
Tapentadol—Vomiting—Tacrolimus—atopic dermatitis	0.000339	0.000835	CcSEcCtD
Tapentadol—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000338	0.000831	CcSEcCtD
Tapentadol—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000337	0.000829	CcSEcCtD
Tapentadol—Rash—Tacrolimus—atopic dermatitis	0.000336	0.000829	CcSEcCtD
Tapentadol—Dermatitis—Tacrolimus—atopic dermatitis	0.000336	0.000828	CcSEcCtD
Tapentadol—Shock—Prednisolone—atopic dermatitis	0.000335	0.000826	CcSEcCtD
Tapentadol—Cough—Triamcinolone—atopic dermatitis	0.000335	0.000825	CcSEcCtD
Tapentadol—Headache—Tacrolimus—atopic dermatitis	0.000334	0.000823	CcSEcCtD
Tapentadol—Oedema—Hydrocortisone—atopic dermatitis	0.000333	0.00082	CcSEcCtD
Tapentadol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000333	0.00082	CcSEcCtD
Tapentadol—Convulsion—Triamcinolone—atopic dermatitis	0.000333	0.000819	CcSEcCtD
Tapentadol—Tachycardia—Prednisolone—atopic dermatitis	0.000333	0.000819	CcSEcCtD
Tapentadol—Convulsion—Methylprednisolone—atopic dermatitis	0.000332	0.000818	CcSEcCtD
Tapentadol—Infection—Hydrocortisone—atopic dermatitis	0.000331	0.000814	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000329	0.000811	CcSEcCtD
Tapentadol—Shock—Hydrocortisone—atopic dermatitis	0.000327	0.000806	CcSEcCtD
Tapentadol—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000326	0.000804	CcSEcCtD
Tapentadol—Arthralgia—Methylprednisolone—atopic dermatitis	0.000326	0.000803	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—atopic dermatitis	0.000326	0.000802	CcSEcCtD
Tapentadol—Anxiety—Methylprednisolone—atopic dermatitis	0.000325	0.000801	CcSEcCtD
Tapentadol—Tachycardia—Hydrocortisone—atopic dermatitis	0.000325	0.0008	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000324	0.000798	CcSEcCtD
Tapentadol—Skin disorder—Hydrocortisone—atopic dermatitis	0.000323	0.000796	CcSEcCtD
Tapentadol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000322	0.000792	CcSEcCtD
Tapentadol—Dry mouth—Triamcinolone—atopic dermatitis	0.00032	0.000787	CcSEcCtD
Tapentadol—Angioedema—Dexamethasone—atopic dermatitis	0.000318	0.000784	CcSEcCtD
Tapentadol—Angioedema—Betamethasone—atopic dermatitis	0.000318	0.000784	CcSEcCtD
Tapentadol—Nausea—Tacrolimus—atopic dermatitis	0.000317	0.000781	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—atopic dermatitis	0.000316	0.000779	CcSEcCtD
Tapentadol—Confusional state—Methylprednisolone—atopic dermatitis	0.000315	0.000777	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—atopic dermatitis	0.000315	0.000775	CcSEcCtD
Tapentadol—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000313	0.000772	CcSEcCtD
Tapentadol—Oedema—Triamcinolone—atopic dermatitis	0.000313	0.000772	CcSEcCtD
Tapentadol—Vertigo—Betamethasone—atopic dermatitis	0.000313	0.000771	CcSEcCtD
Tapentadol—Vertigo—Dexamethasone—atopic dermatitis	0.000313	0.000771	CcSEcCtD
Tapentadol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000313	0.00077	CcSEcCtD
Tapentadol—Syncope—Betamethasone—atopic dermatitis	0.000312	0.00077	CcSEcCtD
Tapentadol—Syncope—Dexamethasone—atopic dermatitis	0.000312	0.00077	CcSEcCtD
Tapentadol—Infection—Triamcinolone—atopic dermatitis	0.000311	0.000767	CcSEcCtD
Tapentadol—Hypotension—Hydrocortisone—atopic dermatitis	0.000311	0.000766	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—atopic dermatitis	0.000311	0.000765	CcSEcCtD
Tapentadol—Shock—Triamcinolone—atopic dermatitis	0.000308	0.000759	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—atopic dermatitis	0.000308	0.000759	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—atopic dermatitis	0.000308	0.000758	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000307	0.000755	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—atopic dermatitis	0.000306	0.000754	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000306	0.000754	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—atopic dermatitis	0.000306	0.000754	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—atopic dermatitis	0.000306	0.000753	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—atopic dermatitis	0.000305	0.000752	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—atopic dermatitis	0.000305	0.000752	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—atopic dermatitis	0.000304	0.000748	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—atopic dermatitis	0.000303	0.000747	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000303	0.000747	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000303	0.000746	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000302	0.000745	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—atopic dermatitis	0.000302	0.000743	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—atopic dermatitis	0.000302	0.000743	CcSEcCtD
Tapentadol—Insomnia—Hydrocortisone—atopic dermatitis	0.000301	0.000741	CcSEcCtD
Tapentadol—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000299	0.000736	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—atopic dermatitis	0.000296	0.000728	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—atopic dermatitis	0.000296	0.000728	CcSEcCtD
Tapentadol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000293	0.000722	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—atopic dermatitis	0.000292	0.00072	CcSEcCtD
Tapentadol—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000289	0.000713	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000287	0.000708	CcSEcCtD
Tapentadol—Fatigue—Hydrocortisone—atopic dermatitis	0.000287	0.000707	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—atopic dermatitis	0.000286	0.000704	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000286	0.000703	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000285	0.000702	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—atopic dermatitis	0.000284	0.0007	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000284	0.0007	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000284	0.0007	CcSEcCtD
Tapentadol—Oedema—Betamethasone—atopic dermatitis	0.000284	0.0007	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—atopic dermatitis	0.000283	0.000698	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—atopic dermatitis	0.000283	0.000697	CcSEcCtD
Tapentadol—Infection—Betamethasone—atopic dermatitis	0.000283	0.000696	CcSEcCtD
Tapentadol—Infection—Dexamethasone—atopic dermatitis	0.000283	0.000696	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—atopic dermatitis	0.000281	0.000693	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—atopic dermatitis	0.000281	0.000692	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000281	0.000692	CcSEcCtD
Tapentadol—Shock—Betamethasone—atopic dermatitis	0.00028	0.000689	CcSEcCtD
Tapentadol—Shock—Dexamethasone—atopic dermatitis	0.00028	0.000689	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—atopic dermatitis	0.000279	0.000688	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—atopic dermatitis	0.000279	0.000687	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000279	0.000687	CcSEcCtD
Tapentadol—Agitation—Prednisone—atopic dermatitis	0.000279	0.000687	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—atopic dermatitis	0.000278	0.000684	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—atopic dermatitis	0.000278	0.000684	CcSEcCtD
Tapentadol—Angioedema—Prednisone—atopic dermatitis	0.000277	0.000683	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—atopic dermatitis	0.000276	0.000679	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000275	0.000678	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000275	0.000677	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000275	0.000677	CcSEcCtD
Tapentadol—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000274	0.000675	CcSEcCtD
Tapentadol—Vertigo—Prednisone—atopic dermatitis	0.000273	0.000671	CcSEcCtD
Tapentadol—Syncope—Prednisone—atopic dermatitis	0.000272	0.00067	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—atopic dermatitis	0.000271	0.000667	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—atopic dermatitis	0.00027	0.000665	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—atopic dermatitis	0.00027	0.000664	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—atopic dermatitis	0.000267	0.000657	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—atopic dermatitis	0.000266	0.000654	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—atopic dermatitis	0.000266	0.000654	CcSEcCtD
Tapentadol—Urticaria—Hydrocortisone—atopic dermatitis	0.000264	0.000651	CcSEcCtD
Tapentadol—Convulsion—Prednisone—atopic dermatitis	0.000263	0.000647	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000259	0.000638	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000259	0.000638	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—atopic dermatitis	0.000258	0.000636	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000258	0.000636	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000258	0.000635	CcSEcCtD
Tapentadol—Anxiety—Prednisone—atopic dermatitis	0.000257	0.000634	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—atopic dermatitis	0.000257	0.000633	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—atopic dermatitis	0.000257	0.000633	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000257	0.000632	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—atopic dermatitis	0.000255	0.000629	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—atopic dermatitis	0.000255	0.000629	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—atopic dermatitis	0.000251	0.000618	CcSEcCtD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000251	0.00282	CbGpPWpGaD
Tapentadol—Dyspepsia—Betamethasone—atopic dermatitis	0.00025	0.000616	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—atopic dermatitis	0.00025	0.000616	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—atopic dermatitis	0.000249	0.000613	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—atopic dermatitis	0.000248	0.000612	CcSEcCtD
Tapentadol—Oedema—Prednisone—atopic dermatitis	0.000248	0.00061	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—atopic dermatitis	0.000248	0.00061	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—atopic dermatitis	0.000247	0.000609	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—atopic dermatitis	0.000247	0.000609	CcSEcCtD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000246	0.00276	CbGpPWpGaD
Tapentadol—Infection—Prednisone—atopic dermatitis	0.000246	0.000606	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000246	0.000605	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000246	0.000605	CcSEcCtD
Tapentadol—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000245	0.000604	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—atopic dermatitis	0.000245	0.000604	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—atopic dermatitis	0.000245	0.000604	CcSEcCtD
Tapentadol—Shock—Prednisone—atopic dermatitis	0.000244	0.0006	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—atopic dermatitis	0.000243	0.000598	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000242	0.00272	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000242	0.00272	CbGpPWpGaD
Tapentadol—Tachycardia—Prednisone—atopic dermatitis	0.000242	0.000595	CcSEcCtD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000242	0.00271	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000241	0.00271	CbGpPWpGaD
Tapentadol—Skin disorder—Prednisone—atopic dermatitis	0.000241	0.000592	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—atopic dermatitis	0.000239	0.00059	CcSEcCtD
Tapentadol—Asthenia—Hydrocortisone—atopic dermatitis	0.000239	0.000588	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000237	0.00266	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000237	0.00266	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000236	0.00265	CbGpPWpGaD
Tapentadol—Pruritus—Hydrocortisone—atopic dermatitis	0.000235	0.00058	CcSEcCtD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000235	0.00264	CbGpPWpGaD
Tapentadol—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000234	0.000577	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—atopic dermatitis	0.000234	0.000577	CcSEcCtD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000234	0.00263	CbGpPWpGaD
Tapentadol—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000231	0.000569	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00023	0.000567	CcSEcCtD
Tapentadol—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.00023	0.00259	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000229	0.00258	CbGpPWpGaD
Tapentadol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000228	0.000561	CcSEcCtD
Tapentadol—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000226	0.00254	CbGpPWpGaD
Tapentadol—Urticaria—Dexamethasone—atopic dermatitis	0.000226	0.000556	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—atopic dermatitis	0.000226	0.000556	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000226	0.000556	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—atopic dermatitis	0.000225	0.000555	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—atopic dermatitis	0.000225	0.000554	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—atopic dermatitis	0.000224	0.000553	CcSEcCtD
Tapentadol—Insomnia—Prednisone—atopic dermatitis	0.000224	0.000552	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—atopic dermatitis	0.000222	0.000548	CcSEcCtD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000222	0.00249	CbGpPWpGaD
Tapentadol—Pruritus—Triamcinolone—atopic dermatitis	0.000222	0.000546	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—atopic dermatitis	0.000221	0.000545	CcSEcCtD
Tapentadol—Dizziness—Hydrocortisone—atopic dermatitis	0.00022	0.000542	CcSEcCtD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000219	0.00246	CbGpPWpGaD
Tapentadol—Dyspepsia—Prednisone—atopic dermatitis	0.000218	0.000537	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—atopic dermatitis	0.000215	0.00053	CcSEcCtD
Tapentadol—Rash—Prednisolone—atopic dermatitis	0.000215	0.000529	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—atopic dermatitis	0.000215	0.000529	CcSEcCtD
Tapentadol—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000214	0.00241	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000214	0.0024	CbGpPWpGaD
Tapentadol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000214	0.000527	CcSEcCtD
Tapentadol—Fatigue—Prednisone—atopic dermatitis	0.000214	0.000526	CcSEcCtD
Tapentadol—Headache—Prednisolone—atopic dermatitis	0.000214	0.000526	CcSEcCtD
Tapentadol—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000213	0.0024	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—PPARA—atopic dermatitis	0.000213	0.00239	CbGpPWpGaD
Tapentadol—Constipation—Prednisone—atopic dermatitis	0.000212	0.000522	CcSEcCtD
Tapentadol—Vomiting—Hydrocortisone—atopic dermatitis	0.000212	0.000521	CcSEcCtD
Tapentadol—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.00021	0.00236	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.00021	0.00236	CbGpPWpGaD
Tapentadol—Rash—Hydrocortisone—atopic dermatitis	0.00021	0.000517	CcSEcCtD
Tapentadol—Dermatitis—Hydrocortisone—atopic dermatitis	0.00021	0.000516	CcSEcCtD
Tapentadol—Headache—Hydrocortisone—atopic dermatitis	0.000209	0.000514	CcSEcCtD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000208	0.00234	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000208	0.00233	CbGpPWpGaD
Tapentadol—Dizziness—Triamcinolone—atopic dermatitis	0.000207	0.00051	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—atopic dermatitis	0.000207	0.000509	CcSEcCtD
Tapentadol—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000207	0.00232	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000206	0.00231	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000205	0.00231	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000205	0.0023	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000205	0.0023	CbGpPWpGaD
Tapentadol—Feeling abnormal—Prednisone—atopic dermatitis	0.000204	0.000503	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—atopic dermatitis	0.000204	0.000502	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—atopic dermatitis	0.000204	0.000502	CcSEcCtD
Tapentadol—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000204	0.00229	CbGpPWpGaD
Tapentadol—Nausea—Prednisolone—atopic dermatitis	0.000202	0.000499	CcSEcCtD
Tapentadol—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000202	0.00227	CbGpPWpGaD
Tapentadol—Pruritus—Dexamethasone—atopic dermatitis	0.000201	0.000495	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—atopic dermatitis	0.000201	0.000495	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000201	0.00225	CbGpPWpGaD
Tapentadol—Vomiting—Triamcinolone—atopic dermatitis	0.000199	0.000491	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—atopic dermatitis	0.000199	0.00049	CcSEcCtD
Tapentadol—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000198	0.00223	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000198	0.00222	CbGpPWpGaD
Tapentadol—Nausea—Hydrocortisone—atopic dermatitis	0.000198	0.000487	CcSEcCtD
Tapentadol—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000198	0.00222	CbGpPWpGaD
Tapentadol—Rash—Triamcinolone—atopic dermatitis	0.000198	0.000487	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—atopic dermatitis	0.000197	0.000486	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—atopic dermatitis	0.000197	0.000486	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000197	0.000485	CcSEcCtD
Tapentadol—Urticaria—Prednisone—atopic dermatitis	0.000197	0.000485	CcSEcCtD
Tapentadol—Headache—Triamcinolone—atopic dermatitis	0.000196	0.000484	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—atopic dermatitis	0.000196	0.000482	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000195	0.000479	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—atopic dermatitis	0.000195	0.000479	CcSEcCtD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000192	0.00215	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000192	0.00215	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000188	0.00211	CbGpPWpGaD
Tapentadol—Dizziness—Dexamethasone—atopic dermatitis	0.000188	0.000463	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—atopic dermatitis	0.000188	0.000463	CcSEcCtD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000187	0.0021	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000187	0.0021	CbGpPWpGaD
Tapentadol—Nausea—Triamcinolone—atopic dermatitis	0.000186	0.000458	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—atopic dermatitis	0.000186	0.000457	CcSEcCtD
Tapentadol—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000184	0.00207	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000184	0.00207	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000184	0.00207	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.000183	0.00206	CbGpPWpGaD
Tapentadol—Hypersensitivity—Prednisone—atopic dermatitis	0.000182	0.000449	CcSEcCtD
Tapentadol—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000181	0.00204	CbGpPWpGaD
Tapentadol—Vomiting—Dexamethasone—atopic dermatitis	0.000181	0.000445	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—atopic dermatitis	0.000181	0.000445	CcSEcCtD
Tapentadol—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000181	0.00203	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.00018	0.00202	CbGpPWpGaD
Tapentadol—Rash—Dexamethasone—atopic dermatitis	0.000179	0.000442	CcSEcCtD
Tapentadol—Rash—Betamethasone—atopic dermatitis	0.000179	0.000442	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—atopic dermatitis	0.000179	0.000441	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—atopic dermatitis	0.000179	0.000441	CcSEcCtD
Tapentadol—Headache—Dexamethasone—atopic dermatitis	0.000178	0.000439	CcSEcCtD
Tapentadol—Headache—Betamethasone—atopic dermatitis	0.000178	0.000439	CcSEcCtD
Tapentadol—Asthenia—Prednisone—atopic dermatitis	0.000178	0.000438	CcSEcCtD
Tapentadol—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000176	0.00197	CbGpPWpGaD
Tapentadol—Pruritus—Prednisone—atopic dermatitis	0.000175	0.000432	CcSEcCtD
Tapentadol—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000175	0.00196	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000174	0.00195	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000171	0.00192	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00017	0.00191	CbGpPWpGaD
Tapentadol—Diarrhoea—Prednisone—atopic dermatitis	0.000169	0.000417	CcSEcCtD
Tapentadol—Nausea—Betamethasone—atopic dermatitis	0.000169	0.000416	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—atopic dermatitis	0.000169	0.000416	CcSEcCtD
Tapentadol—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000168	0.00188	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000167	0.00187	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000165	0.00185	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.000164	0.00185	CbGpPWpGaD
Tapentadol—Dizziness—Prednisone—atopic dermatitis	0.000164	0.000403	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000162	0.00182	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000161	0.00181	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000158	0.00178	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.000158	0.00177	CbGpPWpGaD
Tapentadol—Vomiting—Prednisone—atopic dermatitis	0.000157	0.000388	CcSEcCtD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000156	0.00175	CbGpPWpGaD
Tapentadol—Rash—Prednisone—atopic dermatitis	0.000156	0.000385	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—atopic dermatitis	0.000156	0.000384	CcSEcCtD
Tapentadol—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000156	0.00175	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000156	0.00175	CbGpPWpGaD
Tapentadol—Headache—Prednisone—atopic dermatitis	0.000155	0.000382	CcSEcCtD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000153	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000153	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000152	0.00171	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000149	0.00167	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000148	0.00167	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000148	0.00166	CbGpPWpGaD
Tapentadol—Nausea—Prednisone—atopic dermatitis	0.000147	0.000362	CcSEcCtD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000147	0.00165	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000146	0.00164	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000146	0.00164	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000143	0.00161	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000141	0.00158	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00014	0.00157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000136	0.00153	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000136	0.00153	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000134	0.00151	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000133	0.0015	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.00013	0.00146	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000129	0.00145	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GLB1—atopic dermatitis	0.000129	0.00145	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000129	0.00145	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000128	0.00144	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000126	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000126	0.00141	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ADSL—atopic dermatitis	0.000124	0.00139	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000123	0.00139	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000121	0.00136	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000121	0.00136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000119	0.00134	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000119	0.00133	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000119	0.00133	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000118	0.00133	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000117	0.00131	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000116	0.00131	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000116	0.0013	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.000114	0.00128	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000113	0.00127	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000113	0.00127	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000113	0.00127	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000111	0.00124	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.00011	0.00124	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.00011	0.00124	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000109	0.00122	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000108	0.00122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000108	0.00121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000108	0.00121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000106	0.00119	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000106	0.00119	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000106	0.00119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000106	0.00119	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GLB1—atopic dermatitis	0.000105	0.00118	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000104	0.00117	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000104	0.00117	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000103	0.00115	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000102	0.00115	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000101	0.00113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.000101	0.00113	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ADSL—atopic dermatitis	0.000101	0.00113	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.0001	0.00113	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	9.87e-05	0.00111	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	9.7e-05	0.00109	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	9.68e-05	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	9.57e-05	0.00108	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	9.56e-05	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	9.54e-05	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	9.46e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	9.46e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	9.41e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	9.27e-05	0.00104	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL6—atopic dermatitis	9.23e-05	0.00104	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	8.99e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	8.99e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	8.97e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	8.8e-05	0.000988	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	8.8e-05	0.000988	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	8.79e-05	0.000987	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	8.77e-05	0.000985	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	8.77e-05	0.000985	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.63e-05	0.000969	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	8.55e-05	0.00096	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	8.5e-05	0.000955	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	8.25e-05	0.000927	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	8.24e-05	0.000926	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	8.18e-05	0.000919	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	8.1e-05	0.00091	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	8.06e-05	0.000905	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	7.99e-05	0.000897	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	7.99e-05	0.000897	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	7.84e-05	0.00088	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	7.81e-05	0.000877	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	7.69e-05	0.000863	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	7.69e-05	0.000863	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.64e-05	0.000858	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.6e-05	0.000854	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.57e-05	0.00085	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—IL6—atopic dermatitis	7.54e-05	0.000847	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	7.5e-05	0.000842	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	7.43e-05	0.000834	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	7.36e-05	0.000826	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	7.3e-05	0.00082	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	7.23e-05	0.000812	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	7.18e-05	0.000807	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	7.15e-05	0.000803	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	7.11e-05	0.000798	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.98e-05	0.000783	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	6.85e-05	0.000769	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	6.63e-05	0.000744	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	6.5e-05	0.00073	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	6.5e-05	0.00073	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	6.45e-05	0.000725	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	6.4e-05	0.000719	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NPS—atopic dermatitis	6.37e-05	0.000715	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	6.37e-05	0.000715	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	6.34e-05	0.000711	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	6.27e-05	0.000704	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	6.25e-05	0.000702	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	6.11e-05	0.000686	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	6.01e-05	0.000674	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL5—atopic dermatitis	5.92e-05	0.000665	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	5.81e-05	0.000653	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	5.79e-05	0.00065	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	5.59e-05	0.000627	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPS—atopic dermatitis	5.59e-05	0.000627	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	5.48e-05	0.000615	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	5.45e-05	0.000612	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	5.41e-05	0.000608	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	5.3e-05	0.000595	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL5—atopic dermatitis	5.19e-05	0.000583	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	5.05e-05	0.000567	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GLB1—atopic dermatitis	4.93e-05	0.000553	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	4.91e-05	0.000552	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADSL—atopic dermatitis	4.72e-05	0.000531	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—atopic dermatitis	4.72e-05	0.00053	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	4.72e-05	0.00053	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	4.63e-05	0.00052	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.53e-05	0.000509	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GLB1—atopic dermatitis	4.49e-05	0.000505	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	4.43e-05	0.000497	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.41e-05	0.000496	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL5—atopic dermatitis	4.39e-05	0.000493	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	4.35e-05	0.000488	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.35e-05	0.000488	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADSL—atopic dermatitis	4.31e-05	0.000484	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	4.22e-05	0.000474	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARA—atopic dermatitis	4.19e-05	0.00047	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGF—atopic dermatitis	4.03e-05	0.000452	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	4.01e-05	0.00045	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	3.92e-05	0.00044	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.87e-05	0.000435	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	3.83e-05	0.00043	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	3.81e-05	0.000428	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	3.74e-05	0.00042	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	3.7e-05	0.000415	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.59e-05	0.000403	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGF—atopic dermatitis	3.53e-05	0.000396	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	3.51e-05	0.000395	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	3.43e-05	0.000386	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARA—atopic dermatitis	3.4e-05	0.000382	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	3.36e-05	0.000377	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	3.32e-05	0.000373	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.27e-05	0.000368	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.27e-05	0.000367	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	3.22e-05	0.000362	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	3.13e-05	0.000351	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGF—atopic dermatitis	2.98e-05	0.000335	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.97e-05	0.000334	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	2.91e-05	0.000327	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	2.9e-05	0.000326	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	2.84e-05	0.000319	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.46e-05	0.000276	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	2.37e-05	0.000266	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—atopic dermatitis	2.26e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	2.25e-05	0.000253	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.08e-05	0.000234	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.08e-05	0.000233	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.98e-05	0.000223	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.97e-05	0.000222	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.83e-05	0.000205	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.75e-05	0.000197	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—atopic dermatitis	1.68e-05	0.000188	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	1.67e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.6e-05	0.00018	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.54e-05	0.000173	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.47e-05	0.000165	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.46e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.33e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.17e-05	0.000131	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—atopic dermatitis	9.86e-06	0.000111	CbGpPWpGaD
